Publications

Journal Article Epublish
Electronic publication date
March 31, 2025

View on Pubmed.gov 40160731 | View on doi.org 10.1021/acsomeg...

Double-Layer Magnetic Microspheres with Dual Drug Delivery of Antibacterial and Maintenance Agents for the Treatment of Vaginitis.

Search for publications in this journal ACS Omega - 10(11):11282-11295

  • Haonan Li

    Search for this expert
    1
  • Huijuan Huang

    Search for this expert
    1
  • Sijia Xu

    Search for this expert
    1
  • Hongmei Tian

    Search for this expert
    1
  • Hui Xin

    Search for this expert
    1
  • Xuan Zou

    Search for this expert
    2
  • Ziquan Lv

    Search for this expert
    2
  • Xiangjie Yao

    Search for this expert
    2
  • Yinghua Xu

    Search for this expert
    3
  • Xiaobao Jin

    Search for this expert
    4
  • Shuiqing Gui

    Search for this expert
    5
  • Xuemei Lu

    Search for this expert
    6

Abstract

vaginitis (CV) is the most common fungal infection among gynecological diseases, caused by (). Traditional treatment for CV has led to increased antibiotic resistance, complicating treatment and indiscriminately killing both pathogens and beneficial bacteria in the vagina. Additionally, the inconvenience of traditional vaginal administration and the short residence time of treatments pose significant challenges. We developed a safe and effective combination drug delivery platform featuring magnetic bilayer gel microspheres to combine antibacterial properties and maintain the balance of the microbial community. This platform was characterized through a series of tests evaluating its dissolution, adherence, and retention properties, graded slow release, and antimicrobial effects. studies using CV mice models were conducted to assess antifungal properties, microecological regulation, magnetic residency, safety, and other related aspects. The results demonstrated that the material effectively inhibits the growth of . It also increases the drug's residence time in the body and successfully releases probiotics, thereby improving vaginal microecology and promoting the recovery of inflammation to normal levels. These findings suggest a novel therapeutic approach for managing vaginitis.

References

Contraception. 1999 Feb;59(2):91-5

Carbohydr Polym. 2012 Jul 1;89(3):821-9

Nucleic Acids Res. 2016 Jan 4;44(D1):D1087-93

Microorganisms. 2023 May 05;11(5):

Conflict of interest statement

The authors declare no competing financial interest.

MeSH

Specialties

Copyright

© 2025 The Authors. Published by American Chemical Society.